• An Actual Use Study on Pericoital LNG 1.5mg in Ghana
  • Globally there is currently no modern method that women can use discreetly, only when they need it, easy to remember, and not interrupting intercourse. Experts have been exploring the possibility of developing an on-demand or pericoital (“around the time of sex”) contraceptive for women’s use. Recent research on pericoital LNG 1.5mg suggest the method is safe, reasonably effective, and acceptable to women, recommending further research on pericoital use of LNG 1.5mg. The goal of this actual use study is to provide users with clear advice and support on pericoital use of LNG 1.5mg, monitoring correct and incorrect use in Kenya and Ghana. The study will test the feasibility and acceptability of pharmacy provision of LNG 1.5mg to women, gather real life data on pericoital use of LNG 1.5mg and associated behaviors, and document side effects, if any.

  • Key Findings
  • Preliminary findings coming soon

  • Partners & Funders
  • Camber Collective with funding from

    (a) Bill & Melinda Gates Foundation (b) Children’s Investment Fund Foundation
  • Improving Sexual and Reproductive Health by Strengthening Health Systems in Burkina Faso
  • Provide technical assistance to the Burkina Faso Mstyle=" color: #585858;"inistry of Health in the implementation of the sexual and reproductive health through the design, development, and deployment of innovative technologies to improve on timely data use for the benefit of central, regional, and operational decision-makers. Support with cross border knowledge sharing for increased access and quality of care for comprehensive abortion care services. Lastly, support to institutionalize infrastructure improvement mechanism.

  • Partners & Funders
  • Burkina Faso Ministry of Health with funding from

    (a) Susan T Buffett Foundation